Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 357

1.

Life-threatening Torsades de Pointes resulting from "natural" cancer treatment.

Chan CK, Chan MH, Tse ML, Chan IH, Cheung RC, Lam CW, Lau FL.

Clin Toxicol (Phila). 2009 Jul;47(6):592-4. doi: 10.1080/15563650902997831.

PMID:
19586358
2.

[QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].

Lentini S, Rao ML, Schröder R, Lüderitz B, Bauriedel G.

Dtsch Med Wochenschr. 2001 Dec 7;126(49):1396-400. German.

PMID:
11740632
3.

Fatal cesium chloride toxicity after alternative cancer treatment.

Sessions D, Heard K, Kosnett M.

J Altern Complement Med. 2013 Dec;19(12):973-5. doi: 10.1089/acm.2012.0745.

4.

Cesium-induced QT-interval prolongation in an adolescent.

O'Brien CE, Harik N, James LP, Seib PM, Stowe CD.

Pharmacotherapy. 2008 Aug;28(8):1059-65. doi: 10.1592/phco.28.8.1059. Review.

PMID:
18657021
5.

Acquired long QT syndrome and monomorphic ventricular tachycardia after alternative treatment with cesium chloride for brain cancer.

Dalal AK, Harding JD, Verdino RJ.

Mayo Clin Proc. 2004 Aug;79(8):1065-9. Erratum in: Mayo Clin Proc. 2004 Sep;79(9):1215.

PMID:
15301336
6.
7.

[Drug induced QT prolongation].

Altmann D, Eggmann U, Ammann P.

Wien Klin Wochenschr. 2008;120(5-6):128-35. doi: 10.1007/s00508-008-0940-6. Review. German.

PMID:
18365152
8.

Torsades de Pointes with QT prolongation related to donepezil use.

Takaya T, Okamoto M, Yodoi K, Hata K, Kijima Y, Nakajima H, Nishikawa Y, Kita T, Ito M, Seo T, Kawashima S.

J Cardiol. 2009 Dec;54(3):507-11. doi: 10.1016/j.jjcc.2009.03.011.

9.

The perfect storm: Torsades de Pointes in a child with leukemia.

Bagatell R, Hainstock M, Lowe MC, Barber BJ, Samson RA.

Pediatr Blood Cancer. 2007 Dec;49(7):996-9.

PMID:
16333840
11.

QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.

Arbel Y, Swartzon M, Justo D.

Anticancer Drugs. 2007 Apr;18(4):493-8.

PMID:
17351403
12.

[Lengthening of QT interval by antipsychotic drugs].

Haverkamp W, Deuschle M.

Nervenarzt. 2006 Mar;77(3):276, 278-80, 282-4 passim. Review. German.

PMID:
16052325
13.

[Torsade de Pointes with T wave alternans in a patient receiving moderate dose of chlorpromazine: report of a case].

Ochiai H, Kashiwagi M, Usui T, Oyama Y, Tokita Y, Ishikawa T.

Kokyu To Junkan. 1990 Aug;38(8):819-22. Japanese.

PMID:
2218093
14.

Transient QT prolongation with torsades de pointes tachycardia after ablation of permanent junctional reciprocating tachycardia.

Grimm W, Hoffmann J, Menz V, Maisch B.

J Cardiovasc Electrophysiol. 1999 Dec;10(12):1631-5.

PMID:
10636193
15.

Torsades de pointes associated with terfenadine in a case of liver cirrhosis and hepatocellular carcinoma.

Kamisako T, Adachi Y, Nakagawa H, Yamamoto T.

Intern Med. 1995 Feb;34(2):92-5.

16.

Torsades de pointes caused by Mibefradil.

Gläser S, Steinbach M, Opitz C, Wruck U, Kleber FX.

Eur J Heart Fail. 2001 Oct;3(5):627-30.

17.

Acquired long QT syndrome secondary to cesium chloride supplement.

Vyas H, Johnson K, Houlihan R, Bauer BA, Ackerman MJ.

J Altern Complement Med. 2006 Dec;12(10):1011-4.

PMID:
17212573
18.

Life-threatening ventricular arrhythmia (torsades de pointes) after haloperidol overdose.

Henderson RA, Lane S, Henry JA.

Hum Exp Toxicol. 1991 Jan;10(1):59-62.

PMID:
1673626
19.

Cesium chloride-induced torsades de pointes.

Wiens M, Gordon W, Baulcomb D, Mattman A, Mock T, Brown R.

Can J Cardiol. 2009 Sep;25(9):e329-31.

20.
Items per page

Supplemental Content

Support Center